Correspondence 0001213900-24-063892 from Inmune Bio, Inc. (INMB) (CIK 0001711754) (INMB)
Inmune Bio, Inc. (INMB) (CIK 0001711754)
Date: Aug. 1, 2024 · CIK: 0001711754 · Accession: 0001213900-24-063892
AI Filing Summary & Sentiment
File numbers found in text: 333-279036
Letter
INmune Bio Inc.
225 NE Mizner Blvd., Suite 640
Boca Raton, Florida 33432
(858)-964-372
August 1, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: INmune Bio Inc.
Registration Statement on Form S-3
File No. 333-279036
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on July 30, 2024, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday, August 1, 2024, at 4:00 p.m. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
INMUNE BIO INC.
Show Raw Text
CORRESP
1
filename1.htm
INmune Bio Inc.
225 NE Mizner Blvd., Suite 640
Boca Raton, Florida 33432
(858)-964-372
August 1, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: INmune Bio Inc.
Registration Statement on Form S-3
File No. 333-279036
Ladies and Gentlemen:
Reference is made to our letter,
filed as correspondence via EDGAR on July 30, 2024, in which we requested the acceleration of the effective date of the above-referenced
Registration Statement for Thursday, August 1, 2024, at 4:00 p.m. We are no longer requesting that such Registration Statement be declared
effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
INMUNE BIO INC.
By:
/s/ David Moss
David Moss
Chief Financial Officer